Boston musings.
P2B or P3 may be the burning question.
Pathways??
I wonder if the new HIV/225 patents will be part of a change of tack, with regard to the parameters of the next trial. Will they pursue eradication or will they pursue to prove the human value of the immune response over a longer period.
Is a treatment interruption trial, as mentioned previously by MM in an interview, no longer a pipedream here?
Will they take aim at both?
How?
- Forums
- ASX - By Stock
- BIT
- The Boston CROI connection
The Boston CROI connection, page-18
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
1.7¢ |
Change
-0.011(39.3%) |
Mkt cap ! $15.33M |
Open | High | Low | Value | Volume |
2.2¢ | 2.5¢ | 1.7¢ | $374.7K | 18.97M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 1266038 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 689330 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 1266038 | 0.017 |
13 | 1640362 | 0.016 |
13 | 1766895 | 0.015 |
1 | 250000 | 0.014 |
4 | 1280000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 689330 | 2 |
0.019 | 354299 | 4 |
0.020 | 1688000 | 7 |
0.021 | 110000 | 2 |
0.022 | 388947 | 2 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |